REGENXBIO
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell REGENXBIO and other ETFs, options, and stocks.About RGNX
REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381.
CEOCurran M. Simpson
CEOCurran M. Simpson
Employees353
Employees353
HeadquartersRockville, Maryland
HeadquartersRockville, Maryland
Founded2008
Founded2008
Employees353
Employees353
RGNX Key Statistics
Market cap738.59M
Market cap738.59M
Price-Earnings ratio-4.18
Price-Earnings ratio-4.18
Dividend yield—
Dividend yield—
Average volume766.90K
Average volume766.90K
High today$15.62
High today$15.62
Low today$14.50
Low today$14.50
Open price$15.13
Open price$15.13
Volume450.07K
Volume450.07K
52 Week high$15.80
52 Week high$15.80
52 Week low$5.04
52 Week low$5.04
Stock Snapshot
REGENXBIO(RGNX) stock is priced at $15.06, giving the company a market capitalization of 738.59M. It carries a P/E multiple of -4.18.
On 2026-01-11, REGENXBIO(RGNX) stock traded between a low of $14.50 and a high of $15.62. Shares are currently priced at $15.06, which is +3.9% above the low and -3.6% below the high.
REGENXBIO(RGNX) shares are trading with a volume of 450.07K, against a daily average of 766.9K.
In the last year, REGENXBIO(RGNX) shares hit a 52-week high of $15.80 and a 52-week low of $5.04.
In the last year, REGENXBIO(RGNX) shares hit a 52-week high of $15.80 and a 52-week low of $5.04.
Analyst ratings
92%
of 12 ratingsBuy
91.7%
Hold
8.3%
Sell
0%
People also own
Based on the portfolios of people who own RGNX. This list is generated using Robinhood data, and it’s not a recommendation.